AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Differentiation of High-Risk Drug Reactions

Description

This presentation by an inpatient dermatologist focuses on the differentiation of high-risk drug reactions, exploring various complex drug eruptions such as Acute Generalized Exanthematous Pustulosis (AGEP) and Drug-Induced Hypersensitivity Syndrome (DRESS). Key features and distinctions among these conditions are highlighted, including morphology, timelines, and associated laboratory findings. The significance of close examination of skin, especially in intertriginous areas for detecting early pustules of AGEP, is emphasized. Various case studies illustrate how symptoms can evolve over time, showcasing the complexity of diagnosing and managing these eruptions. The talk addresses rule-breaking instances where patients may not fit typical presentations, such as localized reactions or atypical timelines for onset, particularly with drugs like hydroxychloroquine and antibiotics. Laboratory findings, though insightful, are noted to have variability and may not always indicate the classic signs of these conditions. Ultimately, the talk stresses the importance of clinical judgment and adaptability while recognizing that patients with complex drug reactions may defy conventional categorizations, thereby demanding individualized management strategies.

View more

Conclusions

  • Differentiating between acute generalized exanthematous pustulosis (AGEP), drug-induced hypersensitivity syndrome (DRESS), and Stevens-Johnson syndrome (SJS) is critical due to differing treatment approaches and prognoses.
  • Skin morphology is key in diagnosing high-risk drug eruptions, with specific features suggesting different conditions.
  • Timing of symptom onset following drug exposure can vary significantly between reactions, impacting diagnosis and management.
  • Demographics and clinical characteristics, such as age and comorbidities, influence the presentation and severity of drug reactions.
  • Laboratory tests, including eosinophil and leukocyte counts, play a significant role in supporting diagnosis but are not definitive.
  • The clinical presentation may vary with skin type, necessitating a careful examination of lesions across diverse populations.
  • Certain medications can provoke atypical presentations of common drug reactions, complicating diagnosis.
  • Recognition of 'rule breakers' in clinical presentations is necessary for accurate diagnosis and effective management of complex drug reactions.
  • Gilkey TW, et al. Acad Dermatol Venereol. 2022;36(9)
  • Gallardo MA, et al. J Amer Acad Dermatol. Published online Nov 2022:S0190962222031346.
  • Weiss M, et al. J Euro Acad Dermatol Venereol. 2023:jdv.18940
  • Noe MH, et al. J Am Acad Dermatol. 2019;81(6):1410
  • Chiou CC, et al. J Euro Acad Dermatol Venereol. 2008;22(9):1044
  • Creadore A, et al. JAMA Dermatol. 2022;158(2):176.
  • Kardaun, S.H ., et al. Br J Dermatol. 2013. 169(5): p. 1071
  • Chen YC, et al. Dermatologica Sinica. 2013;31(4):196
  • Bastuji-Garin S, et al. J Invest Dermatol. 2000;115(2):149
  • Ang C et al. J Am Acad Dermatol 2010;63:219-27
  • Park C, et al. Int J Dermatology. Published online June 21, 2022:ijd.16317
  • Soria A, et al. J Amer Acad Dermatol. 2020;82(3):606.